Biliary duct obstruction is a blockage of the ducts that carry bile from the liver to the small intestine. When bile cannot drain normally, it backs up into the liver, raising bilirubin levels and producing jaundice — the yellowing of skin and eyes that is the hallmark of biliary obstruction. Obstruction can develop suddenly or gradually and ranges in cause from the entirely benign (gallstones) to the urgently malignant (pancreatic cancer). MRI with MRCP is the definitive noninvasive test for identifying the cause, level, and extent of obstruction.
Biliary duct obstruction is almost never an isolated diagnosis — it is the consequence of an underlying condition that must be identified and treated. Gallstones migrating into the common bile duct (choledocholithiasis) are the most common cause. Pancreatic masses — particularly pancreatic head adenocarcinoma — are the most feared cause of painless progressive jaundice. Cholangiocarcinoma causes obstruction at the bile duct level itself. When biliary obstruction is complicated by bacterial infection of the static bile, ascending cholangitis — a true medical emergency — develops, with the potential for septic shock and death within hours without urgent drainage. MRCP on MRI creates a noninvasive roadmap of the entire biliary and pancreatic ductal system that directly guides whether ERCP, percutaneous drainage, or surgery is the appropriate next step.
Causes
Gallstones and benign causes.
Common bile duct stones (choledocholithiasis) — most often originating from the gallbladder as a complication of gallstone disease — are the most frequent cause of acute biliary obstruction and the most common cause of acute cholangitis. Benign biliary strictures develop from scar tissue following biliary surgery (particularly bile duct injury during cholecystectomy), liver transplantation (anastomotic strictures at the bile duct-to-bile duct junction), or chronic pancreatitis (which can surround and compress the distal common bile duct as it passes through the pancreatic head). Primary sclerosing cholangitis (PSC) — a chronic autoimmune inflammatory condition — causes multifocal stricturing and beading of the intra- and extrahepatic bile ducts, producing progressive obstruction and significantly elevated cholangiocarcinoma risk over time. Inflammatory conditions including autoimmune pancreatitis (IgG4-related disease) can cause biliary strictures that mimic cholangiocarcinoma on imaging, requiring careful clinical and histologic differentiation.
Malignant causes.
Malignant biliary obstruction most commonly occurs from one of three mechanisms: intrinsic obstruction from cholangiocarcinoma arising within the bile duct wall itself; extrinsic compression from pancreatic head cancer surrounding the distal common bile duct; or extrinsic compression from metastatic lymphadenopathy at the hepatic hilum. Pancreatic head adenocarcinoma produces the classic presentation of painless progressive jaundice — the Courvoisier sign (a palpably enlarged, non-tender gallbladder from chronic distal biliary obstruction without inflammatory scarring) is a classic clinical marker of malignant distal obstruction. Ampullary carcinoma — arising at the ampulla of Vater — and periampullary duodenal cancer are additional causes of distal obstruction. Choledochal cysts — congenital bile duct dilations with significant malignant transformation risk — cause obstruction and are typically diagnosed in childhood but can present in adults.
Symptoms
The hallmark symptom is jaundice — yellow discoloration of the skin and sclera from rising serum bilirubin as bile backs up into the systemic circulation. Dark urine (from bilirubin excreted by the kidneys when serum levels exceed the renal threshold) and pale or clay-colored stools (from the absence of bilirubin-derived pigments in bile reaching the intestine) accompany jaundice. Pruritus (intense itching) results from bile salt deposition in the skin and can be severely debilitating. The clinical pattern of jaundice provides critical diagnostic clues: sudden painful jaundice with fever (Charcot's triad) — pain, fever, jaundice — strongly suggests gallstone cholangitis; painless, slowly progressive jaundice in an older patient with weight loss raises immediate concern for malignancy, particularly pancreatic cancer. Reynold's pentad (Charcot's triad plus mental status change and hypotension) indicates septic shock from suppurative cholangitis and is a surgical emergency. Right upper quadrant pain, nausea, and loss of appetite are variable accompanying symptoms.
Diagnosis
Blood tests show a cholestatic pattern: markedly elevated alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) with conjugated (direct) hyperbilirubinemia — distinguishing biliary obstruction from hepatocellular causes of jaundice, which predominantly elevate ALT and AST. CA 19-9 is elevated in most pancreatic and cholangiocarcinoma cases but lacks specificity. Ultrasound identifies biliary duct dilation (the primary indicator of obstruction) and may identify gallstones or a pancreatic mass as the cause, but has limited visualization of the mid- and distal bile duct due to overlying bowel gas.
An MRI of the abdomen with MRCP (magnetic resonance cholangiopancreatography) is the most accurate noninvasive test for evaluating biliary obstruction and the definitive study before intervention. MRCP acquires heavily T2-weighted sequences in which stationary bile appears intensely bright — creating a detailed "cast" of the entire intra- and extrahepatic biliary tree and the pancreatic duct without contrast injection or radiation. MRCP precisely localizes the level of obstruction (intrahepatic, hilar, suprapancreatic, intrapancreatic, or ampullary), identifies the cause (dark stone filling defects within bright bile, stricture narrowing, mass, or extrinsic compression), and evaluates the proximal ductal dilation pattern. For malignant obstruction, standard MRI sequences characterize the obstructing mass — its size, vascular involvement (portal vein, hepatic artery encasement), lymph node status, and distant metastases — providing the complete staging information that determines resectability. MRCP has replaced diagnostic ERCP for most patients, reserving ERCP for cases where therapeutic intervention is planned simultaneously.
Classification
Biliary obstruction is classified by cause, anatomic level, and acuity — all of which directly determine treatment approach.
- By cause — Benign: Choledocholithiasis, post-surgical stricture, PSC, autoimmune pancreatitis, chronic pancreatitis-related stricture. Treated with stone removal (ERCP), stricture dilation, or surgical bypass.
- By cause — Malignant: Cholangiocarcinoma, pancreatic head cancer, ampullary cancer, metastatic lymphadenopathy. Treated with resection when possible, or biliary stenting for palliation.
- By level — Proximal (hilar/Klatskin): Obstruction at or above the confluence of the right and left hepatic ducts. Most commonly cholangiocarcinoma. Technically challenging to treat — often requires bilateral hepatic duct stenting or complex hepatic surgery.
- By level — Distal: Obstruction in the intrapancreatic or ampullary segment. Most commonly gallstones, pancreatic head cancer, or ampullary cancer. Accessible to ERCP and stenting in most cases.
- Acute cholangitis: Biliary obstruction complicated by bacterial superinfection of static bile. Severity graded by Tokyo Guidelines (I mild, II moderate, III severe/septic shock). Requires urgent biliary drainage and systemic antibiotics.
Treatments
Treatment targets both relief of the obstruction and definitive management of the underlying cause.
ERCP (endoscopic retrograde cholangiopancreatography): ERCP is both the primary diagnostic confirmation tool and the main therapeutic intervention for bile duct stones and distal biliary strictures. The endoscopist cannulates the bile duct from the duodenum, performs sphincterotomy, and extracts stones with balloon or basket catheters. Metal or plastic stents are placed to relieve malignant strictures — plastic stents for temporary relief during staging or bridging to surgery; self-expanding metal stents (SEMS) for definitive palliation of unresectable malignant obstruction, where they provide longer patency. For acute cholangitis, urgent ERCP within 24 hours is indicated to relieve the infected biliary system.
Percutaneous transhepatic cholangiography and drainage (PTCD).
When ERCP is not technically feasible — due to prior gastric bypass surgery, duodenal obstruction, or failed endoscopic access — interventional radiologists place drainage catheters through the skin and liver directly into the bile ducts under imaging guidance. PTCD can decompress the biliary system, allow external or internal drainage, and permit guide-wire access for subsequent stenting. It is particularly useful for proximal hilar obstructions where bilateral hepatic duct access is needed.
Surgical treatment.
Resectable malignant biliary obstruction is treated surgically — pancreaticoduodenectomy (the Whipple procedure) for pancreatic head cancer and distal cholangiocarcinoma, hepatic resection with bile duct reconstruction (hilar hepatectomy) for perihilar cholangiocarcinoma, and ampullectomy for selected ampullary tumors. Biliary-enteric bypass surgery (hepaticojejunostomy) provides durable palliation for unresectable tumors when endoscopic stenting is not feasible. Post-surgical bile duct strictures are repaired with Roux-en-Y hepaticojejunostomy reconstruction.
Treatment of cholangitis.
Acute cholangitis is a medical emergency — IV broad-spectrum antibiotics (covering gram-negative enteric organisms and anaerobes) and urgent biliary drainage within 24 hours for grade II and within hours for grade III (septic shock) are the cornerstones of management. Following successful drainage and antibiotic treatment, the underlying cause is definitively addressed.
Symptom management.
Pruritus from cholestatic bile salt accumulation is treated with cholestyramine (which binds bile salts in the intestine), rifampicin, naltrexone, or sertraline. Fat-soluble vitamin supplementation (vitamins A, D, E, K) is important in chronic cholestasis, as fat absorption is impaired when bile is absent from the intestine.
Get an MRI to Confirm Your Diagnosis
Before surgical planning or starting treatment, a clear MRI diagnosis ensures the right path forward. First Look MRI offers self-pay Abdomen MRI scans — no doctor's order or insurance required — at our locations in Georgia, Texas, and Colorado.